Ignite Creation Date:
2024-05-06 @ 3:53 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04790513
Status:
COMPLETED
Last Update Posted:
2023-03-29
First Post:
2021-03-06
Brief Title:
Trial to Evaluate Efficacy and Safety of LIB003 Evolocumab and Alirocumab in High-risk CVD Patients
Sponsor:
LIB Therapeutics LLC
Organization:
LIB Therapeutics LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-06
First Submit QC Date:
March 9 2021
Study First Post Date:
2021-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-27
Last Update Post Date:
2023-03-29
Last Update Post Date Type:
ACTUAL